Login / Signup

[Optimization of treatment of depression with administration of ethylmethylhydroxypyridine succinate (Mexicor)].

V E MedvedevV I FrolovaA V Palin
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
Administration of Mexicor together with SSRIs leads to improved efficacy and tolerability of antidepressant therapy, and in the future, Mexicor may be recommended as an adjuvant in SSRI therapy for depression.
Keyphrases
  • depressive symptoms
  • sleep quality
  • major depressive disorder
  • open label
  • early stage
  • current status
  • randomized controlled trial
  • mesenchymal stem cells
  • combination therapy